|
๐
|
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
15 auth.
U. Hink,
Huige Li,
H. Mollnau,
M. Oelze,
Edi Matheis,
Mark Hartmann,
M. Skatchkov,
F. Thaiss,
Rolf A. K. Stahl,
A. Warnholtz,
...
Thomas Meinertz,
Kathy K. Griendling,
David G. Harrison,
U. Forstermann,
Thomas Munzel
|
10 |
2001 |
10
๐
|
|
๐
|
Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.
12 auth.
T. Mรผnzel,
Huige Li,
H. Mollnau,
U. Hink,
Edi Matheis,
Mark Hartmann,
...
M. Oelze,
M. Skatchkov,
A. Warnholtz,
Linda Duncker,
Thomas Meinertz,
U. Foฬrstermann
|
7 |
2000 |
7
๐
|
|
๐
|
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
15 auth.
U. Hink,
Huige Li,
H. Mollnau,
M. Oelze,
Edi Matheis,
Mark Hartmann,
M. Skatchkov,
F. Thaiss,
Rolf A. K. Stahl,
A. Warnholtz,
...
Thomas Meinertz,
Kathy K. Griendling,
David G. Harrison,
U. Forstermann,
Thomas Munzel
|
0 |
2001 |
0
๐
|
|
๐ฆ
|
REMAINING RED BLOOD CELL ALLO-ANTIBODIES IN BLOOD PRODUCTS DONATED BY ALLO-SENSITIZED BLOOD DONORS. A COMPARATIVE TITRATION STUDY
Edi Matheis,
A. Bรถhlen-Bodmer,
B. Grossrieder,
K. Hardegger,
A. Schille,
B. Frey
|
0 |
2006 |
0
๐ฆ
|
